发明名称 1-ARYL-2-ACYLAMINO-ETHANE COMPOUNDS AND THEIR USE AS NEUROKININ ESPECIALLY NEUROKININ 1 ANTAGONISTS
摘要 1. A compound of formula I wherein R1 is aryl or heteroaryl; R2 is hydrogen, C1-C7alkyl or aryl-C1-C7alkyl; R3 is hydrogen, C1-C7alkyl, aryl or heteroaryl; R4 is aryl or heteroaryl; X is straight chain C1-C7alkylene, C2-C7 alkenylene or C4-C7alkanedienylene; and Am is an unsubstituted or mono- or di-substituted amino group, a disubstituted amino group being understood as including also an amino group in which the amino nitrogen is bonded into a ring, or a salt thereof. 2. A compound of formula I according to claim 1, wherein Am is an amino group -NR5R6 wherein R5 is hydrogen, unsubstituted or substituted C1-C7alkyl, unsubstituted or substituted C1-C7alkenyl. unsubstituted or substituted C1-C7alkynyl. unsubstituted or substituted cycloalkyl, unsubstituted or substituted (aza, oxa or thia)-cycloalkyl, unsubstituted or substituted benzo-(aza, oxa or thia)-cycloalkyl, aryl, partially hydrated heteroaryl, heteroaryl or (unsubstituted or substituted lower alkyl, unsubstituted or substituted C1-C7alkenyl, aryl or heteroaryl)-sulfonyl; and R6 is hydrogen, unsubstituted or substituted C1-C7alkyl, unsubstituted or substituted C1-C7alkenyl, unsubstituted or substituted C1-C7alkynyl, aryl, heteroaryl or acyl; or - when the radicals R5 and R6 together with the amino nitrogen form a ring - Am may also be an aza-(cycloalkyl, cycloalkenyl, cycloalkynyl, partially hydrated heteroaryl or heteroaryl) radical, bonded via a ring nitrogen atom, which in addition to the amino nitrogen may contain further hetero atoms selected from nitrogen, oxygen and sulfur atoms and which is unsubstituted or substituted. 3. A compound of formula I according to claim 1, wherein R1 is phenyl or pyridyl each of which is unsubstituted or substituted by 1 or 2 substituents selected from the group C1-C7alkyl, trifluoromethyl, halogen, hydroxy, C1-C7alkoxy and nitro; R2 is hydrogen, C1-C7alkyl or phenyl- C1-C7alkyl wherein the phenyl group is unsubstituted or substituted by 1 or 2 substituents selected from the group C1-C7alkyl, trifluoromethyl, halogen, hydroxy and lower alkoxy; R3 is hydrogen, C1-C7alkyl, phenyl, naphthyl or indolyl, with phenyl, naphthyl and indolyl each being unsubstituted or substituted by 1 or 2 substituents selected from the group C1-C7alkyl, trifluoromethyl, halogen, hydroxy and C1-C7alkoxy; R4 is phenyl, naphthyl or indoiyl, each of those radicals being unsubstituted or substituted by 1 or 2 substituents selected from the group C1-C7alkyl, trifluoromethyl. halogen, hydroxy and C1-C7alkoxy; X is C1-C7alkylene, C2-C7alkenylene or C4-C7alkanedienylene; and Am is an amino group -NR5R6 wherein R5 is an aryl radical selected from the group phenyl and naphthyl, that aryl radical being unsubstituted or substituted by from 1 to 3 radicals selected from C1-C7alkyl, halo-C1-C7alkyl, cyctoalkyl, halogen, hydroxy, C1-C7alkoxy, amino, C1-C7alkylamino, di- C1-C7alkylamino, piperidino, morpholino. thiomorpholino, nitro, C1-C7alkanoyl, halo- C1-C7alkanoyl, carboxy, C1-C7alkoxycarbonyt, carbamoyl, C1-C7alkylcarbamoyl, di- C1-C7alkylcarbamoyl, cyano, N- C1-C7alkyl-N-phenyl- C1-C7alkylcarbamoyl; and (phenyl or pyridyl)- C1-C7alkylcarbamoyl wherein the phenyl or pyridyl group is unsubstituted or substituted by C1-C7alkyl, trifluoromethyl, hydroxy, lower alkoxy or halogen; aryl-C1-C7alkyl in which the aryl group is defined in the same manner as an aryl radical R5 and which is unsubstituted or substituted by hydroxy in the C1-C7alkyl moiety; a heteroaryl radical selected from the group pyrrolyl, pyrazolyl, imidazolyl, triazolyl, tetrazolyl, furanyl, thienyl, isoxazolyl, oxazolyl, oxadiazolyl, isothiazolyl, thiazolyl, thiadiazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, indolyl, isoindolyl, benz-imidazolyl. benzotriazolyl, benzofuranyl, benzothienyl, benzoxazolyl, benzothiazolyl, benzopyranyl, quinolinyl and isoquinolinyl, that heteroaryl radical being unsubstituted or substituted by from 1 to 3 radicals selected from C1-C7alkyl, halo- C1-C7alkyl, halogen, hydroxy, C1-C7alkoxy, amino, C1-C7alkylamino, di- C1-C7alkylamino, nitro, C1-C7alkanoyl, halo- C1-C7alkanoyl, carboxy, C1-C7alkoxycarbonyt, carbamoyl, C1-C7alkylcarbamoyl, di- C1-C7alkylcarbamoyl, cyano, phenyl, (C1-C7lalkyl, trifluoromethyl, halogen, hydroxy or C1-C7alkoxy)-phenyl and oxo; heteroaryl- C1-C7alkyl wherein the heteroaryl group is defined in the same manner as a heteroaryl radical R5; a partially hydrated heteroaryl radical selected from the group dihydropyrrolyl, dihydropyrazolyl, dihydroimidazolyt, dihydrofuranyl, dihydrothienyl, dihydrooxazolyl. dihydrothiazolyl, dihydropyridyl and dihydropyrimidinyl, that partially hydrated heteroaryl radical being unsubstituted or substituted by from 1 to 3 radicals selected from C1-C7alkyl, halo- C1-C7alkyl, halogen, hydroxy, C1-C7alkoxy, amino, C1-C7alkylamino, di- C1-C7alkylamino, nitro, C1-C7alkanoyl, halo- C1-C7alkanoyl, carboxy, C1-C7alkoxycarbonyl, carbamoyl, C1-C7alkylcarbamoyl, di- C1-C7alkytcarbamoyl, cyano, phenyl, (C1-C7alkyl, trifluoromethyl, halogen, hydroxy or C1-C7alkoxy)-phenyl and oxo; partially hydrated heteroaryt- C1-C7alkyl wherein the partially hydrated heteroaryl group is defined in the same manner as a partially hydrated heteroaryl radical R5; C1-C7alkyl that is unsubstituted or substituted by from 1 to 3 radicals selected from carboxy, lower alkoxycarbonyl, carbamoyl, C1-C7alkylcarbamoyl, di- C1-C7alkylcarbamoyl, cyano, amino, C1-C7alkylamino, di- C1-C7alkytamino, piperidino, morpholino, thiomorpholino, hydroxy, C1-C7alkoxy, halogen, C1-C7alkanoyl and benzoyl; C3-C7alkenyl that is unsubstituted or substituted by carboxy or by C1-C7alkoxycarbonyl; C3-C7alkynyl that is unsubstituted or substituted by carboxy or by C1-C7alkoxycarbonyl; cycloalkyl that is unsubstituted or substituted by C1-C7alkyl, hydroxy, carboxy or by C1-C7alkoxycarbonyl; cycloalkyl- C1-C7alkyl wherein the cycloalkyl group is defined in the same manner as cycloalkyl R5; (aza, oxa or thia)-cydoalkyl that is unsubstituted or substituted by oxo, C1-C7alkyl, phenyl- C1-C7alkyl, (C1-C7alkyl, trifluoromethyl, halogen, hydroxy or C1-C7alkoxy)-phenyl- C1-C7alkyl, carboxy or C1-C7alkoxycarbonyl; benzo-(aza, oxa or thia)-cycloalkyl that is unsubstituted or substituted by oxo in the cycloaltphatic ring and is unsubstituted or substituted by C1-C7alkyl, trifluoromethyl, halogen, hydroxy or C1-C7alkoxy in the benzo ring; C1-C7alkylsulfonyl; arylsulfonyl wherein the aryl group is defined in the same manner as an aryl radical R5; aryl- C1-C7alkylsulfonyl wherein the aryl group is defined in the same manner as an aryl radical R5; C1-C7alkenylsulfonyl; aryl- C1-C7alkenylsulfonyl wherein the aryl group is defined in the same manner as an aryl radical R5; pyridylsulfonyl that is unsubstituted or substituted by C1-C7alkyl. trifluoromethyl. halogen, hydroxy, C1-C7alkoxy, phenyl- C1-C7alkoxy, (C1-C7alkyl, trifluoromethyl, halogen, hydroxy or C1-C7alkoxy)-phenyl- C1-C7alkoxy, phenyloxy or (C1-C7alkyl, trifluoromethyl, halogen, hydroxy or C1-C7alkoxy)-phenyloxy; R6 is hydrogen, C1-C7alkyl, hydroxy- C1-C7alkyl, (carboxy, C1-C7alkoxycarbonyl, carbamoyl, C1-C7alkylcarbamoyl, di- C1-C7alkytcarbamoyl or cyano)- C1-C7alkyl, C3-C7alkenyl, C3-C7alkynyl, C1-C7alkanoyl, halo- C1-C7alkanoyl. phenyl- C1-C7alkanoyl that is unsubstituted or substituted by C1-C7alkyl, trifluoromethyl, halogen, hydroxy or C1-C7alkoxy in the phenyl ring, or benzoyl that is unsubstituted or substituted by C1-C7alkyl. trifluoromethyl, halogen, hydroxy or C1-C7alkoxy; or wherein -NR5R6 is a cyclic amino group selected from azacycloalkan-1-yl that is unsubstituted or substituted by 1 or 2 substituents selected from C1-C7alkyl, hydroxy- C1-C7alkyl, cyano- C1-C7alkyl, C1-C7alkyl-(sulfinyl or sulfonyl)- C1-C7alkyl, phenyl- C1-C7alkyl-(sulfinyl or sulfonyl)- C1-C7alkyl, (C1-C7alkyl, trifluoromethyl, halogen, hydroxy or C1-C7alkoxy)-phenyl- C1-C7alkyl-(sulfinyl or sulfonyl)- C1-C7alkyl, phenyl-(sulfinyt or sulfonyl)- C1-C7alkyl, (C1-C7alkyl, trifluoromethyl, halogen, hydroxy or C1-C7alkoxy)-phenyl-(sulfinyl or sulfonyl)- C1-C7alkyl, di- C1-C7alkylamino, C1-C7alkanoylamino, hydroxy, C1-C7alkoxy, carboxy, C1-C7alkoxycarbonyl, carbamoyl, C1-C7alkylcarbamoyl, di- C1-C7alkylcarbamoyl, cyano, phenyl, (C1-C7alkyl, trifluoromethyl, halogen, hydroxy or C1-C7alkoxy)-phenyl and spiro-indolone that is unsubstituted or substituted by C1-C7alkyl; diazacycloalkan-1-yl that is unsubstituted or substituted by phenyl, (C1-C7alkyl, trifluoromethyl, halogen, hydroxy or C1-C7alkoxy)-phenyl, pyrimidinyl, (phenyl, C1-C7alkyl-phenyl, trifluoromethyl-phenyl, halo-phenyl, hydroxy-phenyl or C1-C7alkoxy-phenyl)- C1-C7alkyl, (carboxy, C1-C7alkoxycarbonyl, carbamoyl, C1-C7alkylcarbamoyl, di- C1-C7alkylcarbamoyl or cyano)- C1-C7alkyl or by (azacydoalkan-1-yl)-carbonyl- C1-C7alkyl; morpholino; thiomorpholino; and azaheteroaryl-1-yl selected from the group pyrrol-1-yl, pyrazol-1-yl, imidazol-1-yl, triazol-1-yl, tetrazol-1-yl, indol-1-yl, benzimidazol-1-yl and benzotriazol-1-yl, that azaheteroaryl-1-yl radical being unsubstituted or substituted by C1-C7alkyl, di- C1-C7alkyiamino- C1-C7alkyl, cyano- C1-C7alkyl, hydroxy, C1-C7alkoxy, phenyl- C1-C7alkyloxy, C1-C7alkylthio, C1-C7alkanoyl or by halogen; or a salt thereof. 4. A compound of formula I according to claim 1, wherein R1 is phenyl that is unsubstituted or substituted by 1 or 2 substituents selected from the group C1-C7alkyl, trifluoromethyl, halogen, hydroxy and C1-C7alkoxy; R2 is hydrogen, C1-C7alkyl or phenyl- C1-C7alkyl wherein the phenyl group is unsubstituted or substituted by 1 or 2 substituents selected from the group C1-C7alkyl, trifluoromethyl, halogen, hydroxy and C1-C7alkoxy; R3 is hydrogen, C1-C7alkyl, phenyl, naphthyl or indolyl, with phenyl, naphthyl and indolyl each being unsubstituted or substituted by 1 or 2 substituents selected from the group C1-C7alkyl, trifluoromethyl, halogen, hydroxy and C1-C7alkoxy; R4 is phenyl, naphthyl or indolyl, each of those radicals b
申请公布号 EA002348(B1) 申请公布日期 2002.04.25
申请号 EA19990000385 申请日期 1996.02.09
申请人 NOVARTIS AG 发明人 GERSPACHER, MARC;VON SPRECHER, ANDREAS;ROGGO, SILVIO;MAH, ROBERT;OFNER, SILVIO;VEENSTRA, SIEM, JACOB;BERTCHART, CLAUDIA;AUBERSON, YVES;SCHILLING, WALTWER
分类号 C07D249/08;A61K31/16;A61K31/165;A61K31/40;A61K31/4015;A61K31/403;A61K31/404;A61K31/405;A61K31/41;A61K31/415;A61K31/4184;A61K31/425;A61K31/44;A61K31/4427;A61K31/443;A61K31/445;A61K31/4468;A61K31/451;A61K31/454;A61K31/47;A61K31/495;A61K31/496;A61K31/505;A61K31/535;A61K31/5355;A61K31/5375;A61K31/55;A61P1/00;A61P9/00;A61P11/00;A61P11/06;A61P25/00;A61P29/00;A61P37/08;A61P43/00;C07C231/02;C07C231/12;C07C237/22;C07C255/29;C07C311/51;C07D207/27;C07D209/08;C07D209/12;C07D209/18;C07D209/20;C07D211/16;C07D211/22;C07D211/44;C07D211/48;C07D211/58;C07D211/62;C07D213/40;C07D213/70;C07D213/81;C07D215/46;C07D223/12;C07D223/16;C07D231/38;C07D233/60;C07D235/16;C07D235/28;C07D239/28;C07D239/42;C07D241/14;C07D241/20;C07D295/13;C07D295/135;C07D295/14;C07D295/18;C07D295/185;C07D401/12;C07D403/12;C07D405/12;C07D417/12;C07D471/10;C07D521/00 主分类号 C07D249/08
代理机构 代理人
主权项
地址